People | June 23, 2022
Piramal Pharma Solutions appoints Herve Berdou as COO
Brings 25 years of global operations and supply chain experience to Piramal
Brings 25 years of global operations and supply chain experience to Piramal
Guindo will be responsible for leading the development and implementation of the company’s long-term strategy for the Human Health portfolio.
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
We see significant potential in working with oncolytic virus companies and Neo antigen-companies
Gilman will be responsible for all business development and portfolio strategy efforts globally.
New Director supports NASDAQ rule on diversity
Sam Samad will be departing Illumina on July 8, 2022, after serving as CFO for more than five years.
Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas.
Subscribe To Our Newsletter & Stay Updated
